These results suggests that only some heterozygous SMPD1 variants that impact on protein activity lead to an early AOO in the carrier individuals [ 11 ], while others do not seem to show a clear trend or even lead to a later AOO.
← all excerpts
In Silico Analysis of the Molecular-Level Impact of SMPD1 Variants on Niemann-Pick Disease Severity.
1
—
—